1.Anonymous. Life of Craig: he was so curious about himself, he sequenced his own DNA. New Science 2002;174:5.
2.Pollack, A. Another milestone of cloning is reached as a mule is born in Idaho. New York Times May 30, 2003:22.
3.Cornet, M, Fleury, L, Maslo, C, Bernard, JF, Brucker, G. Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hopitaux de Paris: epidemiology of invasive aspergillosis in France. A six-year multicenter survey in the Greater Paris area. J Hosp Infect 2002;51:288–296.
4.Sherertz, RJ, Belani, A, Kramer, S, et al. Impact of air filtration on nosocomial Aspergillus infections. Am J Med 1987;83:709–718.
5.Chazalet, V, Debeaupuis, JP, Sarfati, J, et al. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol 1998;36:1494–1500.
6.Fridkin, SK, Jarvis, WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499–511.
7.Patterson, JE, Zidouh, A, Miniter, P, Andriole, VT, Patterson, TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997;18:104–108.
8.Anaissie, EJ, Stratton, SL, Dignani, MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002;34:780–789.
9.Cooper, EE, O'Reilly, MA, Guest, DI, Dharmage, SC. Influence of building construction work on Aspergillus infection in a hospital setting. Infect Control Hosp Epidemiol 2003;24:472–476.
10.De Rosa, FG, Shaz, D, Campagna, AC, DeUaripa, PF, Khettry, U, Craven, DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha–neutralizing antibody: a possible healthcare-associated case? Infect Control Hosp Epidemiol 2003;24:477–482.
11.Arnow, PM, Andersen, RL, Mainous, PD, Smith, EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978;118:49–53.
12.Walsh, TJ, Dixon, DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989;5:131–142.
13.Symoens, F, Burnod, J, Lebeau, B, et al. Hospital-acquired Aspergillus fumigatus infection: can molecular typing methods identify an environmental source? J Hosp Infect 2002;52:60–67.
14.James, MJ, Lasker, BA, McNeil, MM, Shelton, M, Warnock, DW, Reiss, E. Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flams from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol 2000;38:3612–3618.
15.Symoens, F, Bouchara, JP, Heinemann, S, Nolard, N. Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA. J Hosp Infect 2000;44:273–280.
16.Thio, CL, Smith, D, Merz, WG, et al. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 2000;21:18–23.
17.Rath, PM, Ansorg, R. Value of environmental sampling and molecular typing of aspergilli to assess nosocomial sources of aspergillosis. J Hosp Infect 1997;37:47–53.
18.Anderson, MJ, Gull, K, Denning, DW. Molecular typing by random amplification of polymorphic DNA and M13 southern hybridization of related paired isolates of Aspergillus fumigatus. J Clin Microbiol 1996;34:87–93.
19.Birch, M, Nolard, N, Shankland, GS, Denning, DW. DNA typing of epidemiologically-related isolates of Aspergillus fumigatus. Epidemiol Infect 1995;114:161–168.
20.Buffington, J, Reporter, R, Lasker, BA, et al. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 1994;13:386–393.
21.Symoens, F, Bertout, S, Piens, MA, et al. A longitudinal study of lung transplant recipients infected with Aspergillus: genetic polymorphism of Aspergillus fumigatus. J Heart Lung Transplant 2001;20:970–978.
22.Denning, DW, Venkateswarlu, K, Oakley, KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41:1364–1368.
23.Mondon, P, Brenier, MP, Symoens, F, et al. Molecular typing of Aspergillus fumigatus strains by sequence-specific DNA primer (SSDP) analysis. FEMS Immunol Med Microbiol 1997;17:95–102.
24.Menzies, R, Schwartzman, K, Loo, V, Pasztor, J. Measuring ventilation of patient care areas in hospitals: description of a new protocol. Am J Respir Crit Care Med 1995;152:1992–1999.
25.Adhikari, N, Menzies, R. Community-based tuberculin screening in Montreal: a cost-outcome description. Am J Public Health 1995;85:786–790.
26.Fanning, EA, Menzies, R. Surveillance of medical students for TB urged. CMAJ 1995;152:327–328.
27.Menzies, R, Vissandjee, B, Amyot, D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992;146:752–756.
28.Menzies, D, Adhikari, N, Arietta, M, Loo, V. Efficacy of environmental measures in reducing potentially infectious bioaerosols during sputum induction. Infect Control Hosp Epidemiol 2003;24:483–489.
29.Loudon, RG, Roberts, RM. Droplet expulsion from the respiratory tract. Am Rev Respir Dis 1967;95:435–442.
30.Beck-Sague, CM, Dooley, SW, Hutton, MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280–1286.
